Sitagliptin and Cellulitis - a phase IV clinical study of FDA data

Summary:

Cellulitis is reported as a side effect among people who take Sitagliptin (sitagliptin), especially for people who are male, 60+ old, also take Empagliflozin, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Cellulitis when taking Sitagliptin. It is created by eHealthMe based on reports of 3,929 people who have side effects when taking Sitagliptin from the FDA, and is updated regularly.

What is Sitagliptin?

Sitagliptin has active ingredients of sitagliptin. eHealthMe is studying from 3,933 Sitagliptin users. Check the latest studies of Sitagliptin.

What is Cellulitis?

Cellulitis (infection under the skin) is found to be associated with 2,100 drugs and 2,338 conditions by eHealthMe. Check the latest studies of Cellulitis.

On Jul, 19, 2026

3,929 people reported to have side effects when taking Sitagliptin.
Among them, 23 people (0.59%) have Cellulitis.

Among these 23 people:

What is the gender of people who have Cellulitis when taking Sitagliptin? *

female: 20 %
male: 80 %

What is the age of people who have Cellulitis when taking Sitagliptin? *

What are other drugs people take besides Sitagliptin? *

What are other side effects people have besides Cellulitis? *

Skin Ulcer: 9 people, 39.13%
Diarrhea: 4 people, 17.39%
Gangrene (body tissue dies): 4 people, 17.39%
Necrosis (the death of body tissue): 4 people, 17.39%
Constipation: 3 people, 13.04%
Rashes (redness): 3 people, 13.04%
Memory Loss: 3 people, 13.04%
Pain: 3 people, 13.04%
Abdominal Pain: 3 people, 13.04%
Gastric Ulcer (stomach ulcer): 2 people, 8.70%

What are the existing conditions these people have? *

High Blood Pressure: 2 people, 8.70%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 8.70%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 8.70%
Diabetes: 2 people, 8.70%
Diarrhea: 2 people, 8.70%
Type 2 Diabetes: 2 people, 8.70%
Weight Decreased: 1 person, 4.35%
Blood Pressure Abnormal: 1 person, 4.35%
Burkitt Lymphoma (cancer of the lymphatic system): 1 person, 4.35%
Cardiac Failure: 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Sitagliptin and have Cellulitis?

- Check whether Cellulitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sitagliptin:

Sitagliptin (3,933 reports)

Cellulitis treatments and more:

Cellulitis (75,290 reports)

Browse all side effects of Sitagliptin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cellulitis:

Cellulitis (2,100 drugs)

Browse all the conditions that are associated with Cellulitis:

Cellulitis (2,338 conditions)

Related publications that referenced our studies

Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .
Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on sitagliptin (the active ingredients of Sitagliptin) and Sitagliptin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.